Reply to Aljabali et al. Comment on "Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213". - Abdelazeem B; Abbas KS; Brašić JR (Medicina (Kaunas, Lithuania), 2022)